Display options
Share it on

Front Immunol. 2017 Oct 10;8:1283. doi: 10.3389/fimmu.2017.01283. eCollection 2017.

Exoenzyme T Plays a Pivotal Role in the IFN-γ Production after .

Frontiers in immunology

Mickael Vourc'h, Antoine Roquilly, Alexis Broquet, Gaelle David, Philippe Hulin, Cedric Jacqueline, Jocelyne Caillon, Christelle Retiere, Karim Asehnoune

Affiliations

  1. Laboratoire UPRES EA3826 «Thérapeutiques cliniques et expérimentales des infections», IRS2 - Nantes Biotech, Université de Nantes, Nantes, France.
  2. Intensive Care Unit, Anesthesia and Critical Care Department, Hôtel Dieu, University Hospital of Nantes, Nantes, France.
  3. Etablissement Français du Sang, Nantes, France.
  4. CRCINA, INSERM U1232, CNRS, Université d'Angers, Université de Nantes, Nantes, France.
  5. MicroPICell, Cell and Tissue Imaging Core, UMS Inserm 016/CNRS 3356/FED 4203, Villejuif, France.

PMID: 29067027 PMCID: PMC5641345 DOI: 10.3389/fimmu.2017.01283

[No abstract available.]

Keywords: IL-12; Pseudomonas aeruginosa; innate lymphoid cells; interferon-gamma; natural killer cells; type III secretion system

References

  1. Front Oncol. 2015 Mar 11;5:58 - PubMed
  2. Front Immunol. 2013 Jan 28;4:11 - PubMed
  3. J Immunol. 2003 Jun 1;170(11):5464-9 - PubMed
  4. J Infect. 2017 Feb;74(2):142-152 - PubMed
  5. Infect Immun. 2005 Mar;73(3):1706-13 - PubMed
  6. Biochem J. 2000 Apr 1;347 Pt 1:217-22 - PubMed
  7. Cell Cycle. 2014;13(12 ):1875-84 - PubMed
  8. Front Immunol. 2014 Mar 19;5:105 - PubMed
  9. Science. 2005 Jul 29;309(5735):774-7 - PubMed
  10. Crit Care Med. 2012 Aug;40(8):2320-6 - PubMed
  11. PLoS Pathog. 2009 Aug;5(8):e1000561 - PubMed
  12. Nature. 2000 Aug 31;406(6799):959-64 - PubMed
  13. Res Immunol. 1996 Oct-Dec;147(8-9):487-9 - PubMed
  14. Lancet Infect Dis. 2013 Mar;13(3):260-8 - PubMed
  15. Infect Immun. 1999 Jun;67(6):3151-4 - PubMed
  16. Crit Care Med. 2014 Dec;42(12):e752-61 - PubMed
  17. Leukemia. 1994 Apr;8(4):652-8 - PubMed
  18. J Antimicrob Chemother. 2001 Mar;47(3):247-50 - PubMed
  19. Trends Microbiol. 2006 Feb;14(2):55-8 - PubMed
  20. J Leukoc Biol. 2004 Feb;75(2):163-89 - PubMed
  21. Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2252-7 - PubMed
  22. Immunol Rev. 2004 Dec;202:139-56 - PubMed
  23. Infect Immun. 2008 Apr;76(4):1719-27 - PubMed
  24. Crit Care Med. 2014 Jun;42(6):e441-50 - PubMed
  25. Nat Rev Microbiol. 2009 Sep;7(9):654-65 - PubMed
  26. J Biol Chem. 2003 Aug 29;278(35):32794-800 - PubMed
  27. J Immunol. 2000 Jun 15;164(12 ):6244-51 - PubMed
  28. J Clin Invest. 2007 Feb;117(2):419-27 - PubMed
  29. J Biol Chem. 2013 Sep 13;288(37):26448-62 - PubMed
  30. J Bacteriol. 2002 Feb;184(4):1132-9 - PubMed
  31. Antimicrob Agents Chemother. 2014 Aug;58(8):4384-91 - PubMed
  32. FEMS Microbiol Lett. 2002 Jul 16;213(1):73-9 - PubMed
  33. J Infect Dis. 2014 Sep 1;210(5):814-23 - PubMed
  34. Nat Rev Immunol. 2011 Mar;11(3):176-86 - PubMed
  35. Front Microbiol. 2011 Jul 18;2:155 - PubMed
  36. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6726-6734 - PubMed
  37. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):419-24 - PubMed
  38. Clin Immunol. 2017 Apr;177:87-94 - PubMed

Publication Types